当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 利润表

罗欣药业

(002793)

  

流通市值:49.95亿  总市值:50.03亿
流通股本:10.86亿   总股本:10.88亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入1,826,505,219.291,255,452,798.26662,426,362.853,587,547,040.11
营业收入1,826,505,219.291,255,452,798.26662,426,362.853,587,547,040.11
二、营业总成本2,048,583,469.281,419,691,328.58752,691,953.365,221,444,083.77
营业成本964,727,812.62659,485,848.5354,968,739.842,628,209,164.61
税金及附加14,158,563.918,287,736.434,123,061.640,640,289.68
销售费用686,199,073.3483,456,782.14248,776,003.791,729,957,966.42
管理费用239,595,168.28160,092,242.3885,100,359.34498,965,114.81
研发费用91,165,860.4861,877,702.4638,888,009.55204,725,400.15
财务费用52,736,990.6946,491,016.6720,835,779.24118,946,148.1
其中:利息费用62,220,406.8346,856,081.2124,431,433.11122,671,678.23
其中:利息收入8,933,245.146,162,519.961,352,474.2914,664,321.54
加:公允价值变动收益---2,012,862.44
加:投资收益1,507,275.63,597,351.082,568,234.76161,577,060.37
资产处置收益1,676,264.761,925,831.71214,071.351,736,320.12
资产减值损失(新)-31,568,753.01-5,534,045.23-19,633,984.16-72,660,824.38
信用减值损失(新)-24,604,035.21-4,383,098.282,532,058.01-19,883,818.13
其他收益16,960,725.9612,722,408.544,708,257.8102,182,815.26
营业利润平衡项目0000
四、营业利润-258,106,771.89-155,910,082.5-99,876,952.75-1,458,932,627.98
加:营业外收入17,353,969.4111,205,427.812,901,635.842,968,087.33
减:营业外支出4,456,604.761,523,830.1745,959.976,975,259.29
利润总额平衡项目0000
五、利润总额-245,209,407.24-146,228,484.79-97,721,276.88-1,462,939,799.94
减:所得税费用41,371,292.1315,466,323.85,781,108.46-204,954,207.01
六、净利润-286,580,699.37-161,694,808.59-103,502,385.34-1,257,985,592.93
持续经营净利润-286,580,699.37-161,694,808.59-103,502,385.34-1,508,797,948.02
终止经营净利润---250,812,355.09
归属于母公司股东的净利润-229,511,249.75-126,885,878.87-90,235,051.14-1,225,541,305.23
少数股东损益-57,069,449.62-34,808,929.72-13,267,334.2-32,444,287.7
(一)基本每股收益-0.21-0.12-0.08-0.86
(二)稀释每股收益-0.21-0.12-0.08-0.86
八、其他综合收益5,900,039.8613,056,975.13-3,369,299.2726,165,299.44
归属于母公司股东的其他综合收益5,879,670.5613,011,897.23-3,357,667.126,074,966.36
九、综合收益总额-280,680,659.51-148,637,833.46-106,871,684.61-1,231,820,293.49
归属于母公司股东的综合收益总额-223,631,579.19-113,873,981.64-93,592,718.24-1,199,466,338.87
归属于少数股东的综合收益总额-57,049,080.32-34,763,851.82-13,278,966.37-32,353,954.62
公告日期2023-10-282023-08-292023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑